In-patient Study in Patients With Type 2 Diabetes Mellitus

Summary

This study is a placebo-controlled study in both healthy normal subjects and patients with Type 2 Diabetes Mellitus to assess the levels of exenatide in the bloodstream when it is given for 7 days, and to assess the impact this medication has on various substances in the blood. Assessments include repeat blood sampling and monitoring of any side effects.

Timeline

Start

2005-10

Primary completion

—

Completion

—

Drugs

Indications